Funder
AstraZeneca Argentina S.A.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. World Health Organization. International Agency for Research on Cancer. Globocan Argentina 2020. 2021. https://gco.iarc.fr/today/data/factsheets/populations/32-argentina-fact-sheets.pdf. Accessed 8 July 2024.
2. Datri L, Korbenfeld E, Naveira M, Novas C, Quero LB, Vera K, Romero M, Corsico S, Mendez L, Faura V, Silva C. Clinical characteristics of patients with castration-resistant prostate cancer and alterations in homologous recombination repair genes. RevOnco. 2019;24(2).
3. Parker C, Castro E, Fizazi K, Heidenreich A, Ost P, Procopio G, Tombal B, Gillessen S, ESMO Guidelines Committee. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(9):1119–34. https://doi.org/10.1016/j.annonc.2020.06.011.
4. Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N Engl J Med. 2016;375(5):443–53. https://doi.org/10.1056/NEJMoa1603144.
5. Shah S, Rachmat R, Enyioma S, Ghose A, Revythis A, Boussios S. BRCA mutations in prostate cancer: assessment, implications and treatment considerations. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms222312628.